Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice

Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice

Yan Zhao,1 Huan Wang,2 Yang Yang,2 Wendan Jia,1 Tong Su,1 Yuxin Che,2 Yixin Feng,1 Xuemei Yuan,1 Xuelian Wang2 1Department of Pharmaceutics, School of Pharmacy, China Medical University, Shenyang 110122, People’s Republic of China; 2Department of Microbiology and Parasitology, College of B...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zhao Y, Wang H, Yang Y, Jia W, Su T, Che Y, Feng Y, Yuan X, Wang X
Format: article
Langue:EN
Publié: Dove Medical Press 2020
Sujets:
immunotherapy
human papillomavirus
peptide vaccine
cpg odn adjuvant
liposome
tumor microenvironment
Medicine (General)
R5-920
Accès en ligne:https://doaj.org/article/ee6fcdf5a6464001a5068c56d8ab78d0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/ee6fcdf5a6464001a5068c56d8ab78d0

Documents similaires